Ameriprise Financial Inc A Tyr Pharma Inc Transaction History

Ameriprise Financial Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.63 - $5.61 $41,291 - $88,077	-15,700 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.75 - $7.54 $4,750 - $7,540	-1,000 Reduced 5.99%	15,700 $84,000
Q4 2021 Feb 14, 2022	BUY	$7.29 - $9.5 $121,743 - $158,650	16,700 New	16,700 $125,000

37.2M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.